Lipella Pharmaceuticals Correlations

LIPO Stock

2.80 0.16 5.41%

A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipella Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipella Pharmaceuticals Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Lipella Pharmaceuticals Correlation With Market

Average diversification

The correlation between Lipella Pharmaceuticals Common and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Moving together with Lipella Stock

0.67	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.68	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	MREO	Mereo BioPharma Group	Pair Corr
0.74	PEPG	PepGen	Pair Corr
0.74	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Lipella Stock

0.64	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.6	NAMS	NewAmsterdam Pharma	Pair Corr
0.34	PMVP	Pmv Pharmaceuticals	Pair Corr
0.33	PHVS	Pharvaris BV	Pair Corr
0.65	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.64	AVTE	Aerovate Therapeutics	Pair Corr
0.61	VREX	Varex Imaging Corp	Pair Corr
0.56	AGIO	Agios Pharm	Pair Corr
0.55	CRVS	Corvus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	SNTI	FENC	MNPR	AMTI	AKESF	ADYX	ASCLF	EPRXF	AVXT	TRGNF
SNTI		0.63	-0.58	-0.23	-0.48	-0.15	-0.49	0.44	0.39	0.0	SNTI
FENC	0.63		-0.41	-0.07	-0.57	-0.2	-0.53	0.62	0.24	0.0	FENC
MNPR	-0.58	-0.41		0.33	0.43	-0.1	0.57	-0.42	-0.71	0.0	MNPR
AMTI	-0.23	-0.07	0.33		0.15	-0.14	0.4	-0.01	-0.48	0.0	AMTI
AKESF	-0.48	-0.57	0.43	0.15		0.05	0.55	-0.75	-0.26	0.0	AKESF
ADYX	-0.15	-0.2	-0.1	-0.14	0.05		0.02	-0.15	0.1	0.0	ADYX
ASCLF	-0.49	-0.53	0.57	0.4	0.55	0.02		-0.43	-0.76	0.0	ASCLF
EPRXF	0.44	0.62	-0.42	-0.01	-0.75	-0.15	-0.43		0.24	0.0	EPRXF
AVXT	0.39	0.24	-0.71	-0.48	-0.26	0.1	-0.76	0.24		0.0	AVXT
TRGNF	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		TRGNF
	SNTI	FENC	MNPR	AMTI	AKESF	ADYX	ASCLF	EPRXF	AVXT	TRGNF

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FENC	+ 0.63	SNTI
EPRXF	+ 0.62	FENC
ASCLF	+ 0.57	MNPR
ASCLF	+ 0.55	AKESF
EPRXF	+ 0.44	SNTI
AKESF	+ 0.43	MNPR

High negative correlations

AVXT	- 0.76	ASCLF
EPRXF	- 0.75	AKESF
AVXT	- 0.71	MNPR
MNPR	- 0.58	SNTI
AKESF	- 0.57	FENC
ASCLF	- 0.53	FENC

Risk-Adjusted Indicators

There is a big difference between Lipella Stock performing well and Lipella Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lipella Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SNTI	3.18	(0.33)	0.00	(1.95)	0.00	0.00	7.04	(7.36)	29.17
FENC	3.23	(0.08)	0.00	0.08	3.82	(3.81)	7.14	(6.68)	23.48
MNPR	20.55	10.48	0.89	(2.36)	7.85	(25.53)	15.93	(9.50)	653.56
AMTI	5.08	(0.09)	0.01	0.08	5.70	(6.89)	11.11	(10.34)	36.60
AKESF	4.15	0.99	0.14	(9.60)	3.88	(7.44)	12.00	(7.89)	41.83
ADYX	6.82	2.06	0.00	1.22	0.00	0.00	0.00	0.00	266.67
ASCLF	1.26	0.11	0.00	0.18	0.00	0.00	0.00	0.00	33.04
EPRXF	2.65	(0.74)	0.00	(2.80)	0.00	0.00	5.76	(6.17)	36.58
AVXT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TRGNF	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Lipella Pharmaceuticals Corporate Executives

Elected by the shareholders, the Lipella Pharmaceuticals' board of directors comprises two types of representatives: Lipella Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipella. The board's role is to monitor Lipella Pharmaceuticals' management team and ensure that shareholders' interests are well served. Lipella Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipella Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.

Michael MD

Chief CoFounder

Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC